Cardinal Health (NYSE:CAH) this week announced it began construction on its new pharmaceutical distribution center in Columbus, Ohio. The new 350,000 sq ft. logistics center will serve as a centralized replenishment center for the distribution of over-the-counter consumer health products to support the company’s pharmaceutical business. Dublin, Ohio-based Cardinal Health’s Consumer Health Logistics Center will…
Cardinal Health pharmaceutical segment grows sales 15% in Q2
Cardinal Health (NYSE: CAH) today posted second-quarter results that beat the overall consensus on Wall Street. The Dublin, Ohio-based company reported losses of $130 million, or 50¢ per share, on sales of $51.5 billion for the three months ended December 31, 2022. Cardinal Health’s results swung to a loss versus the same quarter a year…
Cardinal Health, Palantir partner on AI for pharmaceutical products
Cardinal Health (NYSE:CAH) announced that it entered into a strategic collaboration with Palantir Technologies (NYSE:PLTR). The partnership pairs the companies to design a solution to give health systems and hospitals dynamic purchase decision insights. These insights help them quickly improve their bottom line. Dublin, Ohio-based Cardinal Health plans to integrate this solution into Foundry, Palantir’s…
Cardinal Health beats The Street in Q1 — with pharma sales up 15%
Cardinal Health (NYSE: CAH) today reported first-quarter results that beat the consensus forecast on Wall Street, sticking by its full-year EPS guidance. The Dublin, Ohio–based pharma and medtech giant earned $110 million, or 40¢ per share, off $49.6 billion in revenue for the quarter ended Sept. 30, 2022. The bottom line was less than half…
Beckman Coulter Life Sciences names Suzanne Foster as president
Lab automation specialist Beckman Coulter Life Sciences has appointed Cardinal Health veteran Suzanne Foster as president. Foster served as Cardinal Health’s President Health-at-Home subsidiary from January 2020 to March 2022. She has more than 25 years of experience in the healthcare industry, and also sits on the boards of several companies. Foster has also served…
Cardinal Health announces $124M settlement of investors’ opioid suit
Cardinal Health directors’ insurers will pay the company $124 million to settle a stockholder derivative action related to the opioid crisis. The company (NYSE: CAH) on July 22 issued a court-authorized notice to alert investors to a settlement hearing to be held on Oct. 4 in U.S. District Court in Southern Ohio. If the settlement…
Cardinal Health starts Zipline drone deliveries of drugs and medical supplies
Cardinal Health (NYSE: CAH) today started air delivery of pharmaceutical products and medical supplies via Zipline drone in North Carolina. San Francisco-based Zipline won FAA Part 135 air carrier certification for the long-range flights earlier this month. The company flew its first commercial deliveries on June 22 with an initial 16-nautical-mile flight. The flights starting today…
Cardinal Health officials are excited about the Ember Cube: Here’s why
Earlier this year, Cardinal Health (NYSE:CAH) became one of the first healthcare companies to partner with Ember Technologies (Westlake Village, California), a developer of temperature-controlled mugs. At the heart of the partnership is not a smart mug but the Ember Cube, a self-refrigerated, cloud-based shipping container. Cardinal plans on first using the Ember Cube to…
Ember Technologies, Cardinal Health partner on self-refrigerated, cloud-based shipping box
Ember Technologies and Cardinal Health (NYSE:CAH) announced that they are partnering on the Ember Cube digital shipping box. The two companies will collaborate to offer what they are touting as the world’s first self-refrigerated, cloud-based shipping box, according to a news release. They will work together to deliver a cold chain solution designed to ensure product integrity and…
Cardinal Health profits take a big hit in Q2
Cardinal Health (NYSE:CAH) today reported mixed second quarter results and cut its EPS guidance as the company’s Medical segment continues to wrestle with inflation and supply chain problems. The Dublin, Ohio–based pharma and medtech giant reported profits of $49 million, or 17¢ per share, on sales of $45.5 million for the three months ended Dec.…